…
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Exponent, Inc. is a scientific and engineering consulting firm providing failure analysis, product and environmental investigations, and technical studies for corporate and legal clients. Long-term growth may be supported by rising product complexity, regulatory scrutiny, and litigation-driven demand, and the firm appears positioned through multidisciplinary expertise and recurring client work that could support stable revenues.
Material risks include sensitivity to legal and corporate spending cycles, dependence on recruiting and retaining specialized professionals, competition from other consultancies, and variability in project timing and billing.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2024-01-31 | 2023-12-31 | 2023-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2024-01-31 | 2023-12-31 | 2023-01-31 |
| Income before tax | 147.30M | 147.37M | 135.90M | 135.90M | 132.23M |
| Net income | 106.01M | 109.00M | 100.34M | 100.34M | 102.33M |
| Selling general administrative | 25.52M | 22.73M | 344.33M | 24.44M | 287.89M |
| Selling and marketing expenses | - | - | 319.89M | 319.89M | - |
| Gross profit | 145.31M | 142.28M | 135.76M | 135.76M | 478.21M |
| Reconciled depreciation | 10.08M | 9.69M | - | 8.92M | 7.08M |
| Ebit | 147.30M | 119.56M | 111.32M | 111.32M | 133.76M |
| Ebitda | 157.38M | 129.25M | 120.24M | 120.24M | 140.84M |
| Depreciation and amortization | 10.08M | 9.69M | 8.92M | 8.92M | 7.08M |
| Operating income | 119.79M | 119.56M | 111.32M | 111.32M | 140.84M |
| Other operating expenses | 462.23M | 438.96M | 425.44M | 425.44M | 372.45M |
| Interest expense | - | - | - | - | 2.10M |
| Tax provision | 41.29M | 38.37M | - | 35.56M | 29.90M |
| Interest income | 9.31M | 10.00M | - | 7.15M | 2.10M |
| Net interest income | 9.31M | 10.00M | - | 7.15M | 2.10M |
| Income tax expense | 41.29M | 38.37M | 35.56M | 35.56M | 29.90M |
| Total revenue | 582.01M | 558.51M | 536.77M | 536.77M | 513.29M |
| Total operating expenses | 25.52M | 22.73M | 24.44M | 24.44M | 372.45M |
| Cost of revenue | 436.71M | 416.23M | 401.00M | 401.00M | 35.08M |
| Total other income expense net | 27.51M | 27.81M | 24.57M | 24.57M | -8.61M |
| Net income from continuing ops | 106.01M | 109.00M | - | 100.34M | 102.33M |
| Net income applicable to common shares | - | - | - | - | 102.33M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2024-01-31 | 2023-12-31 | 2023-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2024-01-31 | 2023-12-31 | 2023-01-31 |
| Total assets | 808.62M | 777.27M | 662.32M | 646.78M | 586.66M |
| Other current assets | 24.14M | 26.57M | 25.02M | 25.02M | 17.59M |
| Total liab | 418.27M | 356.20M | 306.24M | 290.69M | 265.91M |
| Total stockholder equity | 390.34M | 421.07M | 356.08M | 356.08M | 320.75M |
| Other current liab | 145.37M | 136.15M | 129.41M | 129.41M | 105.82M |
| Common stock | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M |
| Capital stock | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M |
| Retained earnings | 668.42M | 624.15M | 574.08M | 574.08M | 528.81M |
| Other liab | - | - | - | - | 93.54M |
| Good will | 8.61M | 8.61M | 8.61M | 8.61M | 8.61M |
| Other assets | - | - | - | - | 145.35M |
| Cash | 221.93M | 258.90M | 187.15M | 187.15M | 161.46M |
| Total current liabilities | 178.00M | 163.18M | 161.91M | 161.91M | 159.03M |
| Current deferred revenue | 18.87M | 16.37M | 21.71M | 21.71M | 18.83M |
| Net debt | -139.10M | -177.42M | -158.89M | -158.89M | -142.86M |
| Short term debt | 6.89M | 5.39M | 6.30M | 6.30M | 5.26M |
| Short long term debt total | 82.83M | 81.48M | 28.26M | 28.26M | 18.60M |
| Other stockholder equity | -275.86M | -199.36M | -215.09M | -215.09M | -204.54M |
| Property plant equipment | - | - | - | - | 83.55M |
| Total current assets | 427.58M | 446.88M | 379.53M | 379.53M | 349.16M |
| Net tangible assets | - | - | - | - | 312.14M |
| Net receivables | 181.51M | 161.41M | 167.36M | 167.36M | 170.11M |
| Inventory | - | - | 0.00M | 0.00M | - |
| Accounts payable | 6.87M | 5.27M | 4.49M | 4.49M | 29.11M |
| Accumulated other comprehensive income | -2.29M | -3.79M | -2.98M | -2.98M | -3.59M |
| Non currrent assets other | 128.90M | 116.40M | 158.72M | 104.90M | 91.44M |
| Non current assets total | 381.04M | 330.39M | 282.79M | 267.25M | 237.50M |
| Capital lease obligations | 82.83M | 81.48M | 28.26M | 28.26M | 18.60M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-31 | 2022-12-31 |
| Investments | - | -6.94M | -16.36M | -12.04M | -12.04M |
| Change to liabilities | - | - | - | 1.29M | 1.29M |
| Total cashflows from investing activities | -9.39M | -6.94M | -16.36M | -12.04M | -12.04M |
| Total cash from financing activities | -160.43M | -65.11M | -86.01M | -215.98M | -215.98M |
| Change to operating activities | - | - | - | 0.36M | 0.36M |
| Net income | 106.01M | 109.00M | 100.34M | 102.33M | 102.33M |
| Change in cash | -36.97M | 71.75M | 25.69M | -136.23M | -136.23M |
| Begin period cash flow | 258.90M | 187.15M | 161.46M | 297.69M | 297.69M |
| End period cash flow | 221.93M | 258.90M | 187.15M | 161.46M | 161.46M |
| Total cash from operating activities | 131.73M | 144.54M | 127.35M | 93.81M | 93.81M |
| Depreciation | 10.08M | 9.69M | 8.92M | 7.08M | 7.08M |
| Dividends paid | 61.54M | 58.21M | 54.04M | -49.24M | 49.24M |
| Change to account receivables | -23.09M | 1.50M | -0.47M | -33.33M | -33.33M |
| Sale purchase of stock | -97.09M | -5.71M | -24.21M | -155.86M | -155.86M |
| Other cashflows from financing activities | -4.17M | -1.18M | -9.94M | -10.88M | -10.88M |
| Change to netincome | - | - | - | 16.08M | 16.08M |
| Capital expenditures | 9.39M | 6.94M | 16.36M | 12.04M | 12.04M |
| Change in working capital | -1.20M | 1.46M | -5.57M | -31.68M | -31.68M |
| Stock based compensation | 23.80M | 23.24M | 20.36M | 20.36M | 20.36M |
| Other non cash items | 2.99M | 4.45M | 3.23M | 3.08M | 3.08M |
| Free cash flow | 122.34M | 137.60M | 111.00M | 81.76M | 81.76M |
Sector: Industrials Industry: Engineering & Construction
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| EXPO Exponent Inc |
-1.81 2.11% |
84.02 | 32.83 | 29.33 | 6.27 | 8.60 | 5.53 | 24.78 |
| VCISF VINCI SA |
- -% |
124.50 | 14.66 | 12.94 | 1.06 | 2.37 | 1.40 | 8.24 |
| VCISY Vinci SA ADR |
-0.44 1.40% |
30.94 | 14.51 | 12.97 | 1.07 | 2.38 | 1.40 | 8.26 |
| FIX Comfort Systems USA Inc |
52.06 5.40% |
1017.00 | 57.81 | 47.39 | 6.47 | 24.14 | 6.44 | 40.64 |
| FER Ferrovial N.V. |
-0.52 0.88% |
58.71 | 56.50 | 38.76 | 3.96 | 5.93 | 4.13 | 19.50 |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
149 Commonwealth Drive, Menlo Park, CA, United States, 94025
650 326 9400
1212
| Name | Title | Year Born |
|---|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | Pres, CEO & Director | 1969 |
| Mr. Richard L. Schlenker Jr. | Exec. VP, CFO & Corp. Sec. | 1966 |
| Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E. | Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director | 1969 |
| Dr. Steven J. Murray P.E., Ph.D. | Group VP & Principal Engineer | 1975 |
| Dr. Bernard Ross P.E., Ph.D. | Co-Founder, Chairman Emeritus & Principal Engineer | NA |
| Dr. Subbaiah V. Malladi P.E., Ph.D. | CTO & Principal Engineer | 1947 |
| Ms. Sally B. Shepard | Chief HR Officer | 1961 |
| Mr. Eric R. Anderson | VP & Corp. Controller | NA |
| Dr. Robert D. Caligiuri FASM, P.E., Ph.D. | Corp. VP of Materials & Corrosion Engineering and Principal Engineer | 1952 |
| Dr. Paul D. Boehm Ph.D. | Corp. VP of Environmental & Health Sciences and Principal Scientist | 1949 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.